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The present study was designed to explore whether yam could protect the heart from
doxorubicin (DOX)-induced oxidative stress leading to cardiotoxicity in vivo. In this study, the
protective effects of water and ethanol extracts of three varieties of yam, including water
extracts of Dioscorea japonica Thunb., ethanol extracts of D. japonica Thunb., water extracts of
Dioscorea alata, ethanol extracts of D. alata, water extracts of Dioscorea purpurea, and ethanol
extracts of D. purpurea, against DOX-induced cardiotoxicity in experimental mice were eval-
uated. DOX treatment led to significant decreases in the ratio of heart weight to body weight
and heart rate, and increases in blood pressure and the serum level of lactate dehydrogenase,
a marker of cardiotoxicity, were recovered by yam extracts, especially in water extracts of D.
alata. Yam extracts also decreased the cardiac levels of thiobarbituric acid relative substances,
reactive oxygen species, and inflammatory factors, as well as the expression of nuclear factor
kappa B, while ethanol extracts of D. japonica Thunb. and D. purpurea were shown to be more
potent. Moreover, yam extracts had a role in increasing the activities of glutathione peroxidase
and superoxide dismutase, thus improving the DOX-induced alterations in oxidative status in
the heart tissue of DOX-treated mice. All ethanol extracts of yam exhibited their antiapoptotic
abilities on caspase-3 activation and mitochondrial dysfunction, and ethanol extracts of D.
alata still exerted a superior effect. Based on these findings, it can be concluded that yam has
significant cardioprotective properties against DOX-induced damage via its multiple effects on
antioxidant, anti-inflammatory, or antiapoptotic activities.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).ition, Chung Shan Medica
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Doxorubicin (DOX), an anthracyclin antibiotic, has been used
against cancer since 1960s. It is one of the most effective
anticancer drugs. However, studies of cardiotoxic effects of
DOX have been reported [1,2]. Therefore, chemotherapy with
DOX is limited by its cardiotoxicity. The development of cu-
mulative dose-dependent cardiomyopathy may occur many
years after the cessation of DOX treatment. It has been
calculated that approximately 10% of patients treated with
DOX will develop cardiomyopathy and heart failure [3,4].
Owing to the importance of DOX in the chemotherapy treat-
ment for many cancer types, strategies have been tried to
prevent or attenuate the side effects of DOX administration,
including the use of DOX analogs, alternative drug-delivery
methods, and iron-chelating agents [1]. However, so far, the
ability of treatments to prevent or attenuate DOX-induced
damage has been limited, and discovery of novel agents for
reducing its side effects is still needed.
Multiple mechanisms are involved in DOX-induced car-
diotoxicity, such as the increase in cardiac oxidative stress
and lipid peroxidation leading to inflammation- and
apoptosis-related signaling pathway [5,6]. The heart is more
susceptible to oxidative stress-induced damage, because it
has relatively low levels of antioxidant enzymes including
superoxide dismutase (SOD) and catalase [7]. Antioxidants
have been reported to have beneficial effects against DOX-
induced cardiotoxicity in mice and rats [8]. In previous
studies, free radical scavengers, such as vitamin E and ellagic
acid, have been demonstrated to protect from DOX-induced
cardiotoxicity, indicating the involvement of reactive oxygen
species (ROS) and nuclear factor kappa B (NF-kB) in the path-
ogenesis [9,10]. ROS have an important role in the progression
of fibrosis and can influence the expression as well as acti-
vation of transforming growth factor-b (TGF-b) [11], a cytokine
that has been associated with the evolution of tissue fibroin-
flammatory signaling. Acute DOX cardiotoxicity involves
cardiomyocyte apoptosis. It is generally agreed that the
elevated oxidative stress induced by DOX activates signaling
pathways leading to cardiomyocyte apoptosis [12]. Caspase
activity can be influenced by DOX, and mitochondrial
dysfunction is associated with DOX administration [13].
Therefore, any agents with the ability to exhibit antioxidant,
anti-inflammatory, or antiapoptotic activities might provide
some protective effects against DOX.
Yam (Dioscorea spp.), a perennial herb, is distributedmainly
in the tropical and subtropical regions of the world. It is esti-
mated that there are more than 600 species in the world, 93 of
which are found in China and 14 in Taiwan [14]. The tuber of
yam serves as a good source of nutritional supply and staple
food around the world. In addition, yam has been used for
enhancement of health in oriental countries and traditionally
considered as a superior Chinese herb to improve gastroin-
testinal function [15]. Nutritional assessment suggested that
starch is the predominant fraction of yam, and the tuber
contains choline, mucin, allantoin, crude fat, crude fiber,
phytosterols, and steroidal saponins [16]. Yam is most noted
for the abundance of diosgenin, a steroidal saponin, and
the component has been found to ameliorate myocardialPlease cite this article in press as: Chen C-T, et al., Taiwanese and Japa
cardiotoxicity in mice, Journal of Food and Drug Analysis (2016), httpinfarction by its antilipoperoxidant activity [17]. Recently,
diosgenin has also been demonstrated to reduce DOX-induced
cardiotoxicity in mice [18]. This implies that yam can be a
potential cardioprotective agent. Furthermore, many studies
have shown that an extract of yam possesses antioxidant
[14,16,19], anti-inflammatory [16], lipid metabolism [20], and
estrogenic [21] activities. A previous study indicated that a yam
variety (called air potato) has been shown to exert a protective
effect onmyocardial ischemia/reperfusion injury in rats due to
apoptosis and necrosis [22]. Hence, this study aimed to
investigate whether the three varieties of yam, including Dio-
scorea japonica Thunb., Dioscorea alata (cultivars of Ta-Shan line
2), and Dioscorea purpurea (cultivar of Ming-Chien), have pro-
tective effects against DOX-induced cardiac damage in vivo.2. Materials and methods
2.1. Chemicals
Doxorubicin hydrochloride, Tris-HCl, NaCl, ethylenediamin-
etetraacetic acid (EDTA), Tween 80, phenylmethanesulfonyl
fluoride (PMSF), KCl, MgCl2, and sodium dodecyl sulfate (SDS)
were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA).
2.2. Preparation of dried yam extracts
Three varieties of yam, including D. japonica Thunb., D. alata
(cultivars of Ta-Shan line 2), and D. purpurea (cultivar of Ming-
Chien), were used in the present study. All yam tubers were
provided by the Taiwan Agricultural Research Institute (Tai-
chung, Taiwan). The yam tubers were weighed, washed,
peeled, cut into slices, and ground using an electric grinder.
Then, the three parts were blended with water or 75% ethanol
(1:1, w/w) overnight, and further freeze dried to obtain fine
powder. The powders were sealed in polyester bags to prevent
moisture absorption until used for further tests.
2.3. Animals and experimental protocol
Five-week-old male Balb/c mice (15e21 g body weight) were
obtained from National Laboratory Animal Center (National
Science Council, Taipei City, Taiwan). Use of the mice was
approved by the guidelines of the Instituted Animal Care and
Use Committee of Chung Shan Medical University. Mice were
housed on a 12-hour light/dark cycle and fed with mouse
standard chow diet (MF-18; Oriental Yeast Co., Ltd. Tokyo,
Japan); experiments were started after 1-week acclimation.
The mice were randomly divided into eight groups (10 mice
per group) and treated as follows:
Group 1 (control): vehicle
Group 2 (DOX): DOX at 3mg/kg of bodyweight once a week,
i.p.
Group 3 (DOX þ JW): DOX with water extracts of D. japonica
Thunb. (JW)
Group 4 (DOX þ JE): DOXwith ethanol extracts ofD. japonica
Thunb. (JE)
Group 5 (DOX þ AW): DOX with water extracts of D. alata
(AW)nese yam (Dioscorea spp.) extracts attenuate doxorubicin-induced
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(AE)
Group 7 (DOX þ PW): DOX with water extracts of D. pur-
purea (PW)
Group 8 (DOX þ PE): DOX with ethanol extracts of D. pur-
purea (PE)
DOX was administered intraperitoneally to the mice of
Groups 2e8 at a dose of 3 mg/kg once a week for 4 weeks (a
total of 12 mg/kg). At the same time, six of these groups were
receptively orally treated with different yam extracts at the
same doses of 1% per mouse, equivalent to 3 g of daily basal
diets containing 30 mg/mL (w/v) yam extracts, and this
treatment was continued daily for 4 weeks (Figure 1). The
doses and injection regiments for these treatments were
based on the reports published previously [23], with some
modification. At the end of 4 weeks, mice were euthanized by
carbon-dioxide asphyxiation followed by exsanguination.
Cardiac perfusion was performed as described previously [24].
The hearts were excised and weighed, and serum and cardiac
samples were collected and used for analysis as described
below.
2.4. Heart rate, blood pressure monitoring, and serum
lactate dehydrogenase activity
Heart rate and blood pressure were estimated by the tail cuff
method using a blood pressure monitor for rats and mice
(Model MK 2000; Muromachi Kikai Co. Ltd, Tokyo, Japan).
Serum lactate dehydrogenase (LDH) activity was assayed by
commercial kits (Randox, Crumlin, UK).
2.5. Measurement of lipid peroxidation and antioxidant
status in the heart
The level of thiobarbituric acid relative substances (TBARS,
nmol/mg protein) in cardiac tissue was determined by a fluo-
rescence spectrophotometer (excitation at 532 nmand emission
at 600 nm) as described previously [25]. Quantification of TBARSFigure 1 e Schematic diagram of animal experiment.
AE¼ ethanol extracts of D. alata; AW¼water extracts of D.
alata (Ta-Shan); DOX¼ doxorubicin; JE¼ ethanol extracts
of D. japonica Thunb.; JW¼water extracts of D. japonica
Thunb.; PE¼ ethanol extracts of D. purpurea; PW¼water
extracts of D. purpurea.
Please cite this article in press as: Chen C-T, et al., Taiwanese and Japa
cardiotoxicity in mice, Journal of Food and Drug Analysis (2016), httpwas performed by comparison with a standard dosage of
malondialdehyde, the lipid peroxidation product, which is
generated by acid-catalyzed hydrolysis of 1,1,3,3-tetrametho-
xypropane. ROS in cardiac tissue were measured by using
commercial kits (Calbiochem Inc., San Diego, CA, USA). Cardiac
activities of glutathione peroxidase (GPx) and SOD were
determined by commercial assay kits (Calbiochem Inc), and
glutathione (GSH) was analyzed by commercial assay kits
(OxisResearch, Portland, OR, USA).
2.6. Inflammatory cytokine analysis
Heart tissues were homogenized in 10mM Tris-HCl buffered
solution (pH 7.4) containing 2M NaCl, 1mM EDTA, 0.01%
Tween 80, and 1mM PMSF, and centrifuged at 9000g for 30
minutes at 4C. The supernatant was used for cytokine
determination. The levels of tumor necrosis factor-alpha
(TNF-a) and interleukin-6 (IL-6) were assayed by cytoscreen
immunoassay kits (BioSource International, Camarillo, CA,
USA).
2.7. Real-time polymerase chain reaction
Total RNAwas isolated from cells with a guanidinium chloride
procedure and the mRNA levels were analyzed by real-time
quantitative reverse transcriptase polymerase chain reaction
(RT-PCR) as described previously [26]. One microgram of total
RNA was used to generate cDNA, which was amplified using
Taq DNA polymerase. PCR was carried out in 50 mL reaction
mixture containing Taq DNA polymerase buffer [20mM Tris-
HCl at pH 8.4, 50mM KCl, 200mM deoxynucleotide tri-
phosphates (dNTPs), 2.5mMMgCl2, and 0.5mMof each primer]
and 2.5 U Taq DNA polymerase. The specific oligonucleotide
primers for NF-kB, TGF-b, and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH, the housekeeping gene) are as fol-
lows: NF-kB: forward, 50-CAG ACC GCA GTA TCC ATA GC-30,
and reverse, 50-CGT GAA AGG GGT TAT TGT TGG-30; TGF-b:
forward, 50-TGACGTCACTGGAGTTGTACGG-30, and reverse,
50-GGT TCA TGT CAT GGA TGG TGC-30; and GAPDH, forward,
50-TGT GTC CGT CGT GGA TCT GA-30, and reverse, 50-TTG CTG
TTGAAGTCG CAGGAG-30. The cDNAwas amplified under the
following reaction conditions: 95C for 20 seconds, 60C for 1
minute, and 72C for 1 minute. Twenty-eight cycles were
performed for GAPDH, and 40 cycles for NF-kB and TGF-b.
Fluorescence generated from each cycle was quantitatively
analyzed by a Taqman system based on a real-time sequence
detection system (ABI Prism 7700; Perkin-Elmer Inc., Foster
City, CA, USA). Each cDNA sample was triplicated and the
corresponding no-RT mRNA sample was included as a nega-
tive control. GAPDH primers were included in every plate to
avoid sample variations. The mRNA level of each sample for
each gene was normalized to that of the GAPDH mRNA.
2.8. Protein preparation and Western blot analysis
Western blotting was performed according to a method
described previously [18]. The preparation of cytosolic and
nuclear fractions of cells was performed according to the
procedures described by Vasanthi et al [22]. Protein extracts
were subjected to centrifugation at 10,000g for 10 minutes.nese yam (Dioscorea spp.) extracts attenuate doxorubicin-induced
://dx.doi.org/10.1016/j.jfda.2016.09.002
x
tr
a
ct
s,
in
cl
u
d
in
g
JW
,
JE
,
A
W
,
A
E
,
P
W
,
a
n
d
P
E
,
o
n
ca
rd
ia
c
p
h
y
si
ca
l
a
n
d
fu
n
ct
io
n
a
l
p
a
ra
m
e
te
rs
in
D
O
X
-t
re
a
te
d
m
ic
e
.
N
o
rm
a
l
D
O
X
D
O
X
þ
y
a
m
e
x
tr
a
ct
s
D
O
X
þ
JW
D
O
X
þ
JE
D
O
X
þ
A
W
D
O
X
þ
A
E
D
O
X
þ
P
W
D
O
X
þ
P
E
3
0
.4
0
±
1
.7
1
b
2
3
.9
8
±
1
.5
2
a
2
4
.6
0
±
1
.9
0
a
2
3
.6
4
±
1
.7
2
a
2
3
.2
8
±
2
.7
3
a
2
3
.5
3
±
2
.4
4
a
2
3
.0
4
±
0
.9
8
a
2
4
.4
9
±
2
.7
0
a
1
6
8
.7
7
±
1
3
.9
9
c
1
1
5
.6
0
±
1
6
.4
5
a
1
2
4
.3
5
±
2
0
.1
2
a
b
1
2
7
.1
6
±
1
5
.1
0
a
b
1
2
7
.2
1
±
1
4
.3
2
a
b
1
3
9
.2
6
±
9
.2
4
b
1
2
3
.6
8
±
9
.7
3
a
b
1
2
9
.3
1
±
1
7
.8
1
a
b
o
5
.7
5
±
0
.5
2
b
4
.7
9
±
0
.8
7
a
5
.0
5
±
0
.8
2
a
b
5
.3
8
±
0
.6
4
a
b
5
.4
6
±
0
.6
2
b
5
.9
2
±
0
.3
9
b
5
.3
7
±
0
.4
2
a
b
5
.2
8
±
0
.7
3
a
b
6
1
6
.1
0
±
9
.2
5
d
5
9
4
.1
8
±
1
8
.0
2
a
5
9
6
.3
0
±
1
7
.0
1
a
b
6
1
0
.6
0
±
9
.0
9
c
d
6
0
1
.7
5
±
1
5
.9
9
a
b
6
0
3
.9
0
±
9
.4
4
b
c
5
9
9
.5
0
±
1
5
.3
7
a
b
6
0
3
.7
0
±
1
3
.7
7
b
c
1
1
5
.9
5
±
1
1
.5
9
d
1
2
4
.0
9
±
8
.4
2
e
1
0
3
.9
5
±
9
.7
1
b
c
9
6
.4
0
±
1
2
.1
7
a
1
0
3
.7
0
±
9
.9
5
b
c
9
3
.3
5
±
1
2
.9
4
a
1
1
0
.2
5
±
1
1
.3
2
c
d
9
8
.7
5
±
1
1
.8
2
a
1
6
7
.7
7
±
2
4
.2
4
a
2
9
2
.3
5
±
6
6
.9
6
c
2
2
9
.6
9
±
2
7
.7
8
a
b
1
9
1
.9
1
±
3
6
.7
2
a
2
2
1
.9
3
±
5
5
.9
2
a
b
1
6
9
.7
2
±
2
7
.7
1
a
2
0
8
.2
9
±
2
7
.6
2
a
b
2
0
4
.7
4
±
3
3
.1
4
a
b
o
m
m
o
n
le
tt
e
r
d
if
fe
r,
p
<
0
.0
5
.
a
;A
W
¼
w
a
te
r
e
x
tr
a
ct
s
o
f
D
.a
la
ta
(T
a
-S
h
a
n
);
b
p
m
¼
b
e
a
ts
p
e
r
m
in
u
te
;D
O
X
¼
d
o
x
o
ru
b
ic
in
;J
E
¼
e
th
a
n
o
l
e
x
tr
a
ct
s
o
f
D
.j
a
p
on
ic
a
T
h
u
n
b
.;
JW
¼
w
a
te
r
e
x
tr
a
ct
s
o
f
D
.j
a
p
on
ic
a
g
e
n
a
se
;
P
E
¼
e
th
a
n
o
l
e
x
tr
a
ct
s
o
f
D
.
p
u
rp
u
re
a
;
P
W
¼
w
a
te
r
e
x
tr
a
ct
s
o
f
D
.
p
u
rp
u
re
a
;
S
D
¼
st
a
n
d
a
rd
d
e
v
ia
ti
o
n
.
j o u r n a l o f f o o d and d r u g an a l y s i s x x x ( 2 0 1 6 ) 1e94Total protein (10e50 mg per lane) was electrophoresed and
separated on 8e15% SDS-polyacrylamide gels and transferred
to nitrocellulose membranes. After blocking with 5% nonfat
dry milk, the membranes were incubated with the indicated
primary antibodies overnight at 4C. The blots were incubated
with the antibodies against NF-kB, C23, IkBa, caspase-3, cas-
pase-8, caspase-9, poly (ADP-ribose) polymerase-1 (PARP-1),
and b-actin, purchased from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA, USA); b-actin served as an internal control.
The blot was quantified by enhanced chemiluminescence
detection (Amersham Pharmacia Biotech, Little Chalfont,
Bucks, UK).
2.9. Isolation of mitochondria and cytochrome c assay
The preparation of cytosolic and mitochondrial fractions of
cardiac tissuewas performed as described previously [27]. The
isolated hearts were washed in sterile phosphate-buffered
saline, and the mitochondria were isolated according to the
manufacturer’s instructions (Mitochondria Isolation Kit for
Tissue; Pierce, Rockford, IL, USA). Briefly, tissues were minced
after the addition of 800 mL Mitochondria Isolation Reagent A
and carefully homogenized with 20 strokes on ice. The crude
homogenates were then returned to the original tube, and
800mLMitochondria Isolation Reagent C was added. The tube
was centrifuged at 700g for 10 minutes at 48C. The superna-
tant was transferred and centrifuged at 3000g for 15 minutes
at 48C to obtain amore purified fraction ofmitochondria. The
resulting supernatant was transferred into a new tube and
centrifuged at 12,000g to produce a more purified cytosolic
fraction, which was saved for cytochrome c assay. The pellet
contained the isolated mitochondria. Mitochondria Isolation
Reagent C (500 mL) was added to the pellet, and the mixture
was centrifuged at 12,000g for 5 minutes. The mitochondrial
pellet was resuspended in 300 mL of mitochondria isolation
buffer containing 0.1% Triton X-100 and protease inhibitors.
Protein concentrations of both mitochondrial and cytosolic
lysates were determined using BCA Protein Assay Reagents
(Pierce). To detect cytochrome c release into the cytosol,
Western blotting was performed with antibodies against cy-
tochrome c and COX IV, a mitochondrial marker, purchased
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
2.10. Statistical analysis
Results from 10 mice (n ¼ 10) were analyzed and expressed as
means ± standard deviation. Statistical analysis was done by
one-way analysis of variance, and post hoc comparisons were
carried out using Duncan’s multiple-range test. Differences
with p < 0.05 were considered statistically significant.T
a
b
le
1
e
E
ff
e
ct
s
o
f
y
a
m
e
B
o
d
y
w
e
ig
h
t
(g
)
H
e
a
rt
w
e
ig
h
t
(m
g
)
H
e
a
rt
w
e
ig
h
t/
b
o
d
y
w
e
ig
h
t
ra
ti
H
e
a
rt
ra
te
(b
p
m
)
B
lo
o
d
p
re
ss
u
re
(m
m
H
g
)
S
e
ru
m
L
D
H
(U
/L
)
V
a
lu
e
s
a
re
m
e
a
n
±
S
D
,
n
¼
1
0
.
a
e
e
M
e
a
n
s
in
a
ro
w
w
it
h
o
u
t
a
c
A
E
¼
e
th
a
n
o
l
e
x
tr
a
ct
s
o
f
D
.a
la
t
T
h
u
n
b
.;
L
D
H
¼
la
ct
a
te
d
e
h
y
d
ro3. Results
3.1. Effects of yam extracts on DOX-induced
cardiotoxicity
Effect of DOX on cardiotoxic parameters are shown in Table 1.
DOX significantly decreased the body weight, heart weight,
and ratio of heart weight to body weight. Among the groups ofPlease cite this article in press as: Chen C-T, et al., Taiwanese and Japanese yam (Dioscorea spp.) extracts attenuate doxorubicin-induced
cardiotoxicity in mice, Journal of Food and Drug Analysis (2016), http://dx.doi.org/10.1016/j.jfda.2016.09.002
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the DOX-induced loss in the ratio of heart weight to body
weight. Furthermore, heart rate and blood pressure were
assessed after 4 weeks of DOX treatment. Table 1 also shows
that DOX treatment resulted in significant cardiac functional
deterioration, as characterized by a lower heart rate and an
increase in blood pressure as comparedwith the control group
(p < 0.05). The ethanol extracts of yam, including JE, AE, and
PE, can increase heart rate and decrease blood pressure under
DOX treatment. Serum level of LDH was also significantly
elevated in the DOX-alone-treated group. All yam extracts
significantly reduced LDH level as compared with DOX alone
(p < 0.05), while AE was shown to be most potent.
3.2. Effects of yam extracts on DOX-induced alterations
in cardiac oxidative status
To confirm that the induction of oxidative stress was medi-
ated by DOX, tissue lipid peroxidation and antioxidant en-
zymes were also evaluated. As shown in Table 2, DOX
treatment increased TBARS and ROS levels, and decreased
GSH content as well as GPx and SOD activities in the heart. As
compared with DOX alone, all yam extracts lowered ROS and
TBARS levels (p < 0.05). Noticeably, PE significantly retained
GSH content, and recovered cardiac GPx and SOD activities
(p < 0.05, Table 2), indicating that PE could exert a better
antioxidant activity than other extracts.
3.3. Effects of yam extracts on DOX-induced cardiac
inflammation
Previous studies have demonstrated that DOX can induce
cardiotoxicity via activation of both apoptosis and
inflammation-related signaling pathways in the heart [5,6].
Cytokines, particularly TNF-a and IL-6, are involved in the
recruitment and activation of immune cells, both of which
contribute to the development of cardiomyopathy. In the
current study, the levels of both TNF-a and IL-6 in the heart
were markedly elevated by DOX induction compared with
those in the control group (p < 0.05, Figure 2A), indicating a
severe inflammatory injury. In addition, mRNA expressions of
NF-kB and TGF-b, two factors that are related to inflammation,Table 2 e Effects of yam extracts, including JW, JE, AW, AE, PW
status.
Normal DOX
DOX þ JW DO
TBARS (nmol/mg protein) 0.42 ± 0.07a 1.05 ± 0.39b 0.57 ± 0.21a 0.28
ROS (RFU/mg protein) 0.99 ± 0.10a 1.33 ± 0.35b 0.92 ± 0.18a 0.84
GSH (nmol/mg protein) 8.53 ± 1.56cd 4.87 ± 0.72a 6.53 ± 1.49ab 6.98
GPx (U/mg protein) 37.04 ± 12.11c 17.78 ± 4.54a 21.80 ± 5.42a 27.3
SOD (U/mg protein) 7.12 ± 1.42c 4.55 ± 1.61a 5.70 ± 4.62a 6.51
Values are mean ± SD, n ¼ 10.
aed Means in a row without a common letter differ, p < 0.05.
AE ¼ ethanol extracts of D. alata; AW ¼water extracts of D. alata (Ta-Sh
peroxidase; GSH ¼ glutathione; JE ¼ ethanol extracts of D. japonica Thunb
genase; PE ¼ ethanol extracts of D. purpurea; PW ¼water extracts of D.
species; SD ¼ standard deviation; SOD ¼ superoxide dismutase; TBARS ¼
Please cite this article in press as: Chen C-T, et al., Taiwanese and Japa
cardiotoxicity in mice, Journal of Food and Drug Analysis (2016), httpwere measured by real-time PCR. DOX treatment augmented
the cardiac mRNA expression of NF-kB, but not of TGF-b
(Figure 2B). Next, we tested whether yam extracts perturbed
the translocation of NF-kB into the nucleus leading to NF-kB
activation, by immunoblotting analysis of the nucleus fraction
prepared from the heart tissues. The data in Figure 2C
demonstrated that not only a marked increase of nuclear NF-
kB level (Line 1), but also a coincided augment in the cytosolic
level of NF-kB (Line 3) concomitantly with a decrease in the
amount of cytosolic IkBa protein (Line 4) was observed upon
the DOX injection. The nuclear and cytosolic levels of NF-kB
were weaker in the yam extract groups than in the DOX-
alone-treated group. Furthermore, the cytosolic level of IkB
was augmented by DOX, and this, too, was significantly
attenuated by treatment with yam extracts (Figure 2C), sug-
gesting that yam extracts suppressed DOX-induced NF-kB
activation. The yam extract-induced changes in the protein
levels of nuclear and cytosolic NF-kB coincided well with its
mRNA level, as evidenced by real-time PCR results (Figure 2B),
indicating that yam extracts might regulate NF-kB expression
at the transcriptional level. Significantly, when mice were
cotreated with JE, PW, or PE, concomitant decreases in the
levels of TNF-a and IL-6, as well as in mRNA and protein ex-
pressions of NF-kB, were observed, as compared with the
DOX-alone-treated group (p < 0.05, Figure 2).
3.4. Effects of yam extracts on DOX-induced cardiac
apoptosis
To investigate whether the protective effect of yam extracts
against DOX occurred because they inhibited apoptotic path-
ways, we further studied the change in the expression of
caspase-3, one marker of apoptosis, in the heart tissue
(Figure 3A). Caspase-3 is a cytosolic protein that exists nor-
mally as an inactive precursor with a higher molecular weight
(about 32 kDa). It is cleaved proteolytically into fragments of
low molecular weights (11 kDa, 17 kDa, and 20 kDa) when a
cell undergoes apoptosis [28]. In this study, treatment with
DOX induced significantly the cleavages of caspase-3 (p20) and
its upstream caspases, caspase-8 (p23) and caspase-9 (p23), as
well as its downstream factorPARP-1 to 2.05-, 2.93-, 2.12-, and
2.54-fold of that of control, respectively. In the yam extract-, and PE, on DOX-induced alterations in cardiac oxidative
DOX þ yam extracts
X þ JE DOX þ AW DOX þ AE DOX þ PW DOX þ PE
± 0.24a 0.37 ± 0.26a 0.27 ± 0.18a 0.47 ± 0.28a 0.25 ± 0.10a
± 0.08a 0.90 ± 0.10a 0.88 ± 0.02a 0.88 ± 0.10a 0.83 ± 0.16a
± 1.44bc 5.85 ± 0.65ab 6.39 ± 0.88ab 5.69 ± 0.82ab 8.86 ± 1.25d
5 ± 1.29b 23.44 ± 7.70ab 23.57 ± 1.67abc 32.73 ± 6.13bc 33.07 ± 7.18bc
± 2.23bc 5.88 ± 1.65ab 6.22 ± 3.23abc 5.93 ± 2.15bc 6.92 ± 1.74bc
an); bpm ¼ beats per minute; DOX ¼ doxorubicin; GPx ¼ glutathione
.; JW ¼water extracts of D. japonica Thunb.; LDH ¼ lactate dehydro-
purpurea; RFU ¼ relative fluorescence units; ROS ¼ reactive oxygen
thiobarbituric acid relative substances.
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Figure 2 e Effects of yam extracts on the (A) levels of
inflammatory cytokines TNF-a and IL-6, (B) mRNA
expressions of NF-kB and TGF-b, and (C) nuclear
translocation level of NF-kB in heart tissues of mice treated
with DOX for 4 weeks. Values are mean ± SD, n¼ 10. The
nuclear level of NF-kB in the nuclear fraction (Lines 1e2),
and the cytosolic levels of NF-kB and IkBa in the Cyto.
fraction (Lines 3e5) were determined by Western blotting.
C23 and b-actin, respectively, served as internal controls of
nuclear and Cyto. fractions. The protein levels above the
figure represent relative density of the bands normalized
to C23 or b-actin. The determined expression of the protein
was subsequently quantified by densitometric analysis
with that of control being 1.00-fold, as shown just below
the gel data. Results are representative of at least three
independent experiments. aec Means in a row without a
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(Lanes 3e8, Figure 3A). As shown in Figure 3B (Lane 2), DOX
increased the cytosolic level of cytochrome c significantly,
with a concomitant decrease in themitochondria, implicating
mitochondrial dysfunction due to DOX toxicity [29]. Quanti-
tative data showed that the cytosolic level of cytochrome c
was increased to 3.01-fold of that of control in the heart tis-
sues of DOX-treated mice. This effect was significantly sup-
pressed in the groups of DOX plus yam extracts (Lanes 3e8,
Figure 3B). The DOX-induced release of cytochrome c from
mitochondria was almost inhibited in the groups of DOX plus
ethanol extracts of yam.4. Discussion
DOX continues to be an effective and widely used broad-
spectrum chemotherapeutic agent in the treatment of many
types of cancer. However, many side effects limit its benefits
[1]. Cardiotoxicity, a major side effect of DOX, can be observed
in clinical patients and animal studies. DOX-induced cardio-
myopathy is an important public health concern because this
may limit its therapeutic use for clinical patients [3]. The
search for cardioprotective agents will continue to rely on
increasing our understanding of the mechanisms of DOX-
induced cardiotoxicity and how to counteract and overcome
it. The present study examined the possible protective effects
of different species of yam currently available and commonly
consumed in Taiwan on the cardiac function in a mouse
model of DOX-induced cardiotoxicity. Our data indicated that
water or ethanol extracts of three varieties of yams (D. japonica
Thunb., D. alata, and D. purpurea), including JW, JE, AW, AE,
PW, and PE, cotreated with DOX for 4 weeks improved cardiac
physical and functional parameters during the DOX-induced
cardiotoxicity, as demonstrated by improvements in the
body weight, heart weight, and ratio of heart weight to body
weight, as well as in cardiac function, as indicated by
increased heart rates, lower blood pressure, and lower serum
LDH levels (Table 1). The preservation of heart function was
associated with a decrease in the level of oxidative stress
(Table 2) and inflammation status in cardiomyocytes
(Figure 2), as well as a significant reduction in apoptotic
response (Figure 3).
To date, a lot of strategies using pharmaceutical agents to
reduce DOX cardiotoxicity have been tested in many experi-
mental models and clinical studies. Use of antioxidants is one
promising pharmaceutical approach to prevent DOX car-
diotoxicity [10,30]. DOX generates ROS, which have beencommon letter differ, p < 0.05. AE¼ ethanol extracts of D.
alata; AW¼water extracts of D. alata (Ta-Shan);
Cyto.¼ cytosolic; DOX¼ doxorubicin; IL¼ interleukin;
JE¼ ethanol extracts of D. japonica Thunb.; JW¼water
extracts of D. japonica Thunb.; NF-kB¼ nuclear factor
kappa B; PE¼ ethanol extracts of D. purpurea; PW¼water
extracts of D. purpurea; SD¼ standard deviation; TGF-
b¼ transforming growth factor-b; TNF-a¼ tumor necrosis
factor-alpha.
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Figure 3 e Effects of yam extracts on (A) the protein
expressions of caspase-3, caspase-8, caspase-9, and PARP-
1, and (B) the release of Cyt. c in heart tissues of mice
treated with DOX for 4 weeks. The protein levels of Cyt. c
from Mito. (Lines 1e2) and Cyto. (Lines 3e4) fractions were
determined by Western blotting. COX IV and b-actin,
respectively, served as internal controls of Mito. and Cyto.
fractions. The protein levels above the figure represent
relative density of the bands normalized to COX IV or b-
actin. The determined expression of the protein was
subsequently quantified by densitometric analysis with
that of control being 1.00-fold, as shown just below the gel
data. Results are representative of at least three
independent experiments. AE¼ ethanol extracts of D.
alata; AW¼water extracts of D. alata (Ta-Shan); Cyt.
c¼ cytochrome c; Cyto.¼ cytosolic; DOX¼ doxorubicin;
IL¼ interleukin; JE¼ ethanol extracts of D. japonica
Thunb.; JW¼water extracts of D. japonica Thunb.;
Mito.¼mitochondrial; PARP-1¼ poly (ADP-ribose)
polymerase-1; PE¼ ethanol extracts of D. purpurea;
PW¼water extracts of D. purpurea.
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cardiotoxicity. Myocardial tissue is more susceptible to ROS
damage due to a fewer number of antioxidant enzymes pre-
sent in the heart [31]. Production of ROS damages the
myocardium and results in an increase in cell membrane
permeability leading to leakage of LDH, as reported earlier [32].
Therefore, free radical scavengers have been proposed to
protect cardiac tissues from oxidative stress and relieve car-
diotoxicity. In this study, generation of lipid peroxidation isPlease cite this article in press as: Chen C-T, et al., Taiwanese and Japa
cardiotoxicity in mice, Journal of Food and Drug Analysis (2016), httpconfirmed by elevated TBARS in the DOX treatment group.
The inhibitory effects of yam extracts were observed on the
levels of not only TBARS but also ROS (Table 2), with a
concomitant decrease in the serum level of LDH (Table 1),
suggesting that yam extracts play important roles in protec-
tion against oxidative stress. Moreover, yam extracts restored
the GSH level, and GPx and SOD activities in the heart tissue
(Table 2), supporting the antioxidant effect of yam extracts
against DOX-induced oxidative damage. Previous studies
have demonstrated that yam possesses antioxidant property
in various oxidative conditions [14,16,19]. The antioxidant
supplements have been suggested to patients with cancer to
enhance the benefits of treatment [33]. Consistent with pre-
vious reports, this study confirmed that dietary supplements
of yam, especially in three ethanol extracts, may provide a
helpful effect on the heart against DOX. Compared with the
same ethanol extraction of yam, AE was shown to be most
potent on elevating the GSH level, and GPx and SOD activities.
A previous study has demonstrated oxidative stress-
induced NF-kB activation in neonatal rat cardiomyocytes,
which leads to cardiomyocyte loss [34]. The cardioprotective
activity of yam extracts was further supported by the
decreasing extent of inflammation status. Our present study
showed that yam extracts declined the mRNA and protein
levels of NF-kB (Figures 2B and 2C) and cardiac levels of proin-
flammation cytokines, including TNF-a and IL-6 (Figure 2A).
Although all ethanol extracts of yam improved the cardiac
inflammation status, JE and PE exerted superior effects to AE.
Several studies have shown that the DOX-induced
apoptosis plays an important role in the cardiotoxicity
caused by ROS production or oxidative stress [5,27]. Caspase-3
activity can be influenced by DOX [12]. As shown in Figure 3,
the results confirmed that DOX significantly increased
caspase-3, caspase-9, caspase-8, and PARP-1 activation, as
well as mitochondrial dysfunction. In contrast, yam extract
cotreatments dramatically reduced the DOX-dependent the
expressions of cleavage caspases and PARP-1 (Figure 3A), and
the cytosolic release of cytochrome c (Figure 3B). However, the
detailed mechanism(s) of the inhibitory effect of yam extracts
on caspase activation is not well understood. The data further
indicated that AE could have a better antiapoptotic effect
against DOX than other yam extracts. Similar results were
found for DOX-induced cardiotoxic parameters, such as LDH,
as shown in Table 1. By contrast, the anti-inflammatory ca-
pacity of ethanol extracts of yam directly correlated with their
antioxidant activity (PE  JE > AE). As a whole, these results
revealed that the ethanol extracts of yam possess higher
cardioprotective activities than the water extracts in each
tested, including cardiac physical and functional parameters,
measurement of lipid peroxidation, ROS and antioxidant en-
zymes, inflammatory cytokines analysis, real-time PCR,
Western blotting, and cytochrome c assay. Looking back on
our and other previous studies, Qin et al [35] reported that
ethanol extracts of yam contains 28.34% diosgenin. Diosgenin
is known to significantly ameliorate the cardiac damage
induced by DOX [18]. According to these findings, diosgenin
may be a candidate mediator, which is responsible for the
antioxidant, anti-inflammatory, or antiapoptotic activities in
the ethanol extracts of yam. However, further work is needed
to clarify this issue.nese yam (Dioscorea spp.) extracts attenuate doxorubicin-induced
://dx.doi.org/10.1016/j.jfda.2016.09.002
j o u r n a l o f f o o d and d r u g an a l y s i s x x x ( 2 0 1 6 ) 1e98In conclusion, these results demonstrate that yam extracts
were able to reduce the DOX-induced cardiotoxicity in mul-
tiple ways. Our results suggest that yam can be a promising
agent to prevent DOX-induced cardiotoxicity via its antioxi-
dant, anti-inflammatory, and antiapoptotic effects.Conflicts of interest
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